OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of Tumor-Induced Osteomalacia Syndrome

Tumor-induced Osteomalacia (TIO) and Epidermal Nevus Syndrome with osteomalacia (ENS) are rare conditions in which ectopic production of FGF23 by tumor (TIO) and bone (ENS) lead to renal phosphate wasting, impaired 1,25(OH)(2)D synthesis, osteomalacia, fractures, weakness, fatigue and decreased mobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan De Beur, Suzanne, Miller, Paul, Weber, Thomas, Peacock, Munro, Insogna, Karl, Kumar, Rajiv, Luca, Diana, Theodore-Oklota, Christina, Lampl, Kathy, San Martin, Javier, Carpenter, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554835/
http://dx.doi.org/10.1210/js.2019-OR13-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554835/
http://dx.doi.org/10.1210/js.2019-OR13-1

Ejemplares similares